BioMed Research International / 2015 / Article / Fig 2

Research Article

Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment

Figure 2

Selection of the interferon beta-treated and untreated cohorts aged ≥50 at interferon beta eligibility date. BCMS clinic, British Columbia Multiple Sclerosis clinic; DMD, disease-modifying drug; EDSS, Expanded Disability Status Scale; RRMS, relapsing-remitting multiple sclerosis; and SPMS, secondary progressive multiple sclerosis.The sum of the individual reasons (numbers) exceeds the total number of patients in some boxes because some patients met more than one condition.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.